MINNEAPOLIS, Sept. 28 /PRNewswire/ — Incisive Surgical, Inc.
today announced that the U.S. Patent and Trademark Office issued a
Notice of Allowance for another key patent application, “Mechanical
Method and Apparatus for Tissue Fastening.” The allowed
claims include subject matter covering the method of the INSORB
Skin Closure technology and specific stapler features. The Company
has now sold over 500,000 INSORB® Absorbable Skin Staplers
since its launch in January 2005. The INSORB Absorbable Skin
Stapler is a revolutionary new method of skin closure.
Patients now have a more comfortable, convenient and cosmetic
choice for closure of their surgical incisions. This unique
device has won several national awards, including the 2006 Wall
Street Journal Technology Innovation of the Year Award for
medical devices. The Company will be exhibiting at the Annual
Meeting of the American College of Surgeons being held in
Washington, D.C. from October 4 – 6.
“The issuance of the Notice of Allowance by the Patent Office is
further recognition of the important technological advance
represented by the INSORB Absorbable Skin Stapler to patients,
clinicians and health care facilities,” said John L. Shannon, Jr.,
president and chief executive officer. The INSORB Absorbable
Skin Stapler offers the speed of metal skin staplers with the
cosmetic results and comfort of absorbable sutures. The
INSORB Stapler uses bioabsorbable staples that are placed
underneath the skin and dissolve in the body within a matter of
months. The staples, which are comprised of the same material
as the leading bioabsorbable sutures, break down naturally, meaning
there is no need for post-operative removal. Clinical
experience has shown that patients overwhelmingly prefer the
absorbable skin staples compared to metal skin staples. With
the issuance of the new patent, Incisive Surgical will hold 5 US
Patents and 1 Japanese P
‘/>”/>
